Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Studies have shown that lidocaine can reduce opioid consumption by 20-50% in the perioperative period.
Studies have shown that lidocaine can reduce opioid consumption by 20-50% in the perioperative period.
By reducing opioid consumption, lidocaine can also decrease the incidence of opioid-related side effects, such as nausea, vomiting, and respiratory depression.
Lidocaine's analgesic effects can improve patient satisfaction and reduce anxiety related to pain
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention group | Active Comparator | intervention group recieve inj lidocaine |
|
| Control group | Placebo Comparator | control group receive Normal saline |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Lidocaine 2% without vessel constrictor | Drug |
|
| Measure | Description | Time Frame |
|---|---|---|
| Peri-operative pain | Visual Analog pain scale to rate pain scale comprises 0 to 10 score 0 minimum to 10 Maximum | at 2 hours, 4 hours, 6 hours |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Hanesh Tanwani Dr Hanesh Tanwani | Liaquat National Hospital and Medical College | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Liaquat National Hospital and Medical College | Karachi | Sindh | Pakistan |
Not provided
| Label | URL |
|---|---|
| Systemic lidocaine decreased the perioperative opioid analgesic requirements but failed to reduce discharge time after ambulatory surgery Allannah McKay 1, Antje Gottschalk, Annette Ploppa, Marcel E Durieux, Danja S Groves | View source |
Not provided
*Informed consent*: Participants may not have provided informed consent for their data to be shared, which could raise ethical concerns.
Patient confidentiality*: Sharing IPD could compromise patient confidentiality and anonymity, potentially harming participants or their families.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010146 | Pain |
| D010149 | Pain, Postoperative |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D011183 | Postoperative Complications |
Not provided
Not provided
| ID | Term |
|---|---|
| D008012 | Lidocaine |
| D000077330 | Saline Solution |
| ID | Term |
|---|---|
| D000083 | Acetanilides |
| D000813 | Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Normal Saline | Drug | Normal saline used is an iv fluid given for fluid replacement |
|
| D010335 | Pathologic Processes |
| Aniline Compounds |
| D000588 | Amines |
| D000077324 | Crystalloid Solutions |
| D007552 | Isotonic Solutions |
| D012996 | Solutions |
| D004364 | Pharmaceutical Preparations |